Vildagliptin: the first innovative DDP-4 inhibitor by Edvin Villkhauer

Subjects: “…dipeptidyl peptidase-4 inhibitor…”
Get full text

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs by M Elle Saine, Dean M Carbonari, Craig W Newcomb, Melissa S Nezamzadeh, Kevin Haynes, Jason A Roy, Serena Cardillo, Sean Hennessy, Crystal N Holick, Daina B Esposito, Arlene M Gallagher, Harshvinder Bhullar, Brian L Strom, Vincent Lo Re

Subjects: Get full text

SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS by M. Ganeva

Subjects: “…: dipeptidyl peptidase-4 inhibitors…”
Get full text

Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes by Junko Oya, Mika Shimizu, Ryo Kubota, Rika Suda, Tomoko Nagkagami

Subjects: “…Dipeptidyl peptidase‐4 inhibitor…”
Get full text

Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase‐4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas by Wei‐Sheng Chen, Tzu‐Min Lin, Yu‐Sheng Chang, Yu‐Chuan Shen, Hui‐Ching Hsu, Tzu‐Tung Kuo, Shu‐Chuan Chen, Jin‐Hua Chen, Chi‐Ching Chang

Subjects: “…dipeptidyl peptidase‐4 inhibitors…”
Get full text

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data by Cristina Hernández, Hugo Ramos, Anne Létondor, Rafael Simó

Subjects: Get full text

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy by Gagik Radikovich Galstyan, Svetlana Viktorovna Sergeeva

Subjects: “…dipeptidyl peptidase-4 inhibitors…”
Get full text

Research progress on the association of bullous pemphigoid with type 2 diabetes mellitus by ZHANG Ruohan, WANG Zhenying

Subjects: Get full text

Hypoglycemic Therapy and the Course of Post-Covid Syndrome, is There a Connection? by G. A. Ignatenko, A. E. Bagriy, O. A. Prikolota, A. V. Prikolota, K. E. Mogilevskaya

Subjects: Get full text

Angioedema following venipuncture in a patient on angiotensin‐converting enzyme inhibitor and dipeptidyl peptidase‐IV inhibitor therapy: A case report by Adrien Bénic, Adrien Boyard, Alexan Pogossian, Laurent Misery, Anne‐Marie Roguedas‐Contios

Subjects: Get full text

Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications by Yaswanth Kuthati, Venkata Naga Goutham Davuluri, Chih-Shung Wong

Subjects: Get full text

Development and Validation of a Highly Sensitive LC–MS/MS Method for the Precise Quantification of Sitagliptin in Human Plasma and Its Application to Pharmacokinetic Study by Yuna Song, Wang-Seob Shim, Eunseo Song, Yebeen Park, Bo-Hyung Kim, Sangmin Lee, Eun Kyoung Chung, Kyung-Tae Lee

Subjects: Get full text

Comparative risk of cancer associated with SGLT inhibitors and DPP-4 inhibitors in patients with diabetes: a systematic review and meta-analysis by Hamed Hajishah, Parsa Mazloom, Amirhossein Salehi, Danial Kazemi, Reza Samiee, Hossein Majlesi, Mohammad Javad Amini, Arefeh Meyari, Negin Safari Dehnavi, Masood Zangi

Subjects: Get full text

Cardiovascular Events and Heart Failure in Patients With Type 2 Diabetes Treated With Dipeptidyl Peptidase-4 Inhibitors: A Meta-Analysis by Adili Tuersun, PhD, Shufen Cui, BS, Li Han, BS, Alimu Aikebaier, BS, Yanyan Shi, BS, Gang Cheng, PhD, Lei Cheng, BS, Guo Ma, PhD

Subjects: Get full text

Comparative Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes by Takefumi Kishimori, Takao Kato, Atsuyuki Wada, Akira Tani, Ryosuke Yamaji, Jumpei Koike, Yoshihiro Iwasaki, Takehiro Matsumoto, Takafumi Yagi, Masaharu Okada

Subjects: “…dipeptidyl peptidase 4 inhibitor…”
Get full text

Association of long-term use of dipeptidyl peptidase-4 inhibitors with the risk of diabetic retinopathy in patients with diabetes mellitus: a real-world evidence study by Yu-Ching Li, Yu-Ching Li, Yu-Hsiang Kuan, Yu-Hsiang Kuan, Yih Yang, Shuo-Yan Gau, Kun-Yu Su, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee, Chien-Ying Lee

Subjects: Get full text

Impact of Dipeptidyl Peptidase-4 Inhibitors on Aminotransferases Levels in Patients with Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomiz... by Gang Ma, MD, Song Zhang, MD, Baozhong Yu, MD

Subjects: Get full text

Assessment of the effectiveness and safety of fixed-dose combination of alogliptin and pioglitazone in real clinical practice: results of the PROsperity study by M. V. Shestakova, M. I. Kharakhulakh, Y. A. Belolipetsky

Subjects: Get full text

Sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic macular edema and the need for intravitreal injection by Yoo-Ri Chung, Chungwoon Kim, Eunzee Lee, Kihwang Lee

Subjects: Get full text

Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study by Arunkumar Krishnan, Carolin V. Schneider, Hendrik-Tobias Arkenau, Ezequiel Matias Mauro, Alejandro Forner, W. Scott Butsch, Declan Walsh, Saleh A. Alqahtani

Subjects: Get full text